Episode Details

With stocks at or near record highs, our market guest says the gains can continue and is highlighting the parts of the market that he sees as undervalued. Plus, a blowout finish for biotech stocks to end the year – we’ll speak to one CEO whose company is coming off its best day ever thanks to the success of a heart disease drug. And our latest check on commercial real estate takes us down to Miami.